Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody (Q42937533)
Jump to navigation
Jump to search
scientific article published on 23 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody |
scientific article published on 23 July 2013 |
Statements
1 reference
Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody (English)
1 reference
M Reilly
1 reference
R M Miller
1 reference
M H Thomson
1 reference
V Patris
1 reference
P Ryle
1 reference
L McLoughlin
1 reference
P Mutch
1 reference
P Gilboy
1 reference
C Miller
1 reference
M Broekema
1 reference
B Keogh
1 reference
W McCormack
1 reference
J van de Wetering de Rooij
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference